Article citationsMore>>

Tabernero, J., Lenz, H.J., Siena, S., et al. (2015) Analysis of Circulating DNA and Protein Biomarkers to Predict the Clinical Activity of Regorafenib and Assess Prognosis in Patients with Metastatic Colorectal Cancer: A Retrospective, Exploratory Analysis of the Correct Trial. The Lancet Oncology, 16, 937-948.
https://doi.org/10.1016/S1470-2045(15)00138-2

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top